233 related articles for article (PubMed ID: 28836585)
1. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.
Yu ZC; Zhou PJ; Wang XH; Françoise B; Xu D; Zhang WX; Chen B
Acta Pharmacol Sin; 2017 Nov; 38(11):1566-1579. PubMed ID: 28836585
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
de Winter BC; van Gelder T; Glander P; Cattaneo D; Tedesco-Silva H; Neumann I; Hilbrands L; van Hest RM; Pescovitz MD; Budde K; Mathot RA
Clin Pharmacokinet; 2008; 47(12):827-38. PubMed ID: 19026038
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Mathot RA
Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.
Zhao W; Fakhoury M; Deschênes G; Roussey G; Brochard K; Niaudet P; Tsimaratos M; André JL; Cloarec S; Cochat P; Bensman A; Azougagh S; Jacqz-Aigrain E
J Clin Pharmacol; 2010 Nov; 50(11):1280-91. PubMed ID: 20147615
[TBL] [Abstract][Full Text] [Related]
5. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen.
Reséndiz-Galván JE; Romano-Aguilar M; Medellín-Garibay SE; Milán-Segovia RDC; Niño-Moreno PDC; Jung-Cook H; Chevaile-Ramos JA; Romano-Moreno S
Eur J Pharm Sci; 2020 Jul; 150():105370. PubMed ID: 32387086
[TBL] [Abstract][Full Text] [Related]
7. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Chinese Renal Allograft Recipients After Administration of EC-MPS.
Chen B; Shao K; An HM; Shi HQ; Lu JQ; Zhai XH; Liu XX; Wang XH; Xu D; Zhou PJ
J Clin Pharmacol; 2019 Apr; 59(4):578-589. PubMed ID: 30537048
[TBL] [Abstract][Full Text] [Related]
9. Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients.
Xie XC; Li J; Wang HY; Li HL; Liu J; Fu Q; Huang JW; Zhu C; Zhong GP; Wang XD; Sun PP; Huang M; Wang CX; Li JL
Acta Pharmacol Sin; 2015 May; 36(5):644-50. PubMed ID: 25864649
[TBL] [Abstract][Full Text] [Related]
10. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
de Winter BC; Mathot RA; Sombogaard F; Neumann I; van Hest RM; Doorduijn JK; van Gelder T
Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients.
Punyawudho B; Lertdumrongluk P; Somparn P; Kittanamongkolchai W; Traitanon O; Avihingsanon Y; Vadcharavivad S
Int J Clin Pharmacol Ther; 2012 Apr; 50(4):272-80. PubMed ID: 22456298
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
Barau C; Furlan V; Debray D; Taburet AM; Barrail-Tran A
Br J Clin Pharmacol; 2012 Sep; 74(3):515-24. PubMed ID: 22329639
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis.
Yang CL; Sheng CC; Liao GY; Su Y; Feng LJ; Xia Q; Jiao Z; Xu DJ
J Clin Pharm Ther; 2021 Dec; 46(6):1564-1575. PubMed ID: 34312870
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.
Zhao W; Elie V; Baudouin V; Bensman A; André JL; Brochard K; Broux F; Cailliez M; Loirat C; Jacqz-Aigrain E
Br J Clin Pharmacol; 2010 Apr; 69(4):358-66. PubMed ID: 20406220
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil.
Ling J; Shi J; Jiang Q; Jiao Z
Eur J Clin Pharmacol; 2015 Jan; 71(1):95-106. PubMed ID: 25327506
[TBL] [Abstract][Full Text] [Related]
17. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
Musuamba FT; Mourad M; Haufroid V; Demeyer M; Capron A; Delattre IK; Delaruelle F; Wallemacq P; Verbeeck RK
J Clin Pharmacol; 2012 Dec; 52(12):1833-43. PubMed ID: 22207766
[TBL] [Abstract][Full Text] [Related]
18. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.
Baldelli S; Merlini S; Perico N; Nicastri A; Cortinovis M; Gotti E; Remuzzi G; Cattaneo D
Pharmacogenomics; 2007 Sep; 8(9):1127-41. PubMed ID: 17924828
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis.
Romano-Aguilar M; Reséndiz-Galván JE; Medellín-Garibay SE; Milán-Segovia RDC; Martínez-Martínez MU; Abud-Mendoza C; Romano-Moreno S
Lupus; 2020 Aug; 29(9):1067-1077. PubMed ID: 32539658
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Shaw LM; Mathot RA
Clin Pharmacokinet; 2009; 48(7):463-76. PubMed ID: 19691368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
